N. Binder

发表

Paternal obesity in a rodent model affects placental gene expression in a sex-specific manner.

D. Gardner, N. Hannan, S. Tong, 2015, Reproduction.

Novel approaches to combat preeclampsia: from new drugs to innovative delivery.

N. Hannan, S. Tong, N. Binder, 2019, Placenta.

Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia

S. Walker, N. Hannan, S. Tong, 2015, Hypertension.

Placental Growth Factor Is Secreted by the Human Endometrium and Has Potential Important Functions during Embryo Development and Implantation

D. Gardner, L. Salamonsen, N. Hannan, 2016, PloS one.

Endometrial signals improve embryo outcome: functional role of vascular endothelial growth factor isoforms on embryo development and implantation in mice.

D. Gardner, L. Salamonsen, N. Hannan, 2014, Human reproduction.

LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast.

S. Kane, S. Walker, N. Hannan, 2021, Pregnancy hypertension.

Sofalcone Upregulates the Nuclear Factor (Erythroid-Derived 2)–Like 2/Heme Oxygenase-1 Pathway, Reduces Soluble fms–Like Tyrosine Kinase-1, and Quenches Endothelial Dysfunction: Potential Therapeutic for Preeclampsia

N. Hannan, S. Tong, N. Binder, 2015, Hypertension.

Placental SEMA3B expression is not altered in severe early onset preeclampsia.

N. Hannan, S. Tong, N. Binder, 2014, Placenta.

EGFL7 gene expression is regulated by hypoxia in trophoblast and altered in the plasma of patients with early preeclampsia.

C. Whitehead, N. Hannan, S. Tong, 2018, Pregnancy hypertension.

Esomeprazole and sulfasalazine in combination additively reduce sFlt-1 secretion and diminish endothelial dysfunction: potential for a combination treatment for preeclampsia.

Tuong-Vi Nguyen, N. Hannan, S. Tong, 2020, Pregnancy hypertension.

Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia

Tuong-Vi Nguyen, N. Hannan, S. Tong, 2018, PloS one.

Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion

C. Whitehead, N. Hannan, S. Tong, 2015, Hypertension.

Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries—A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development

N. Hannan, S. Tong, N. Binder, 2022, International journal of molecular sciences.

Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease

N. Hannan, N. Binder, Sally Beard, 2022, International journal of molecular sciences.

Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors.

N. Hannan, S. Tong, N. Binder, 2022, Pregnancy hypertension.

Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction.

N. Hannan, S. Tong, N. Binder, 2020, Pregnancy hypertension.

Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity

A. Shub, T. Johns, N. Hannan, 2015, Hypertension.

The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health

N. Hannan, N. Binder, Sally Beard, 2022, Life Science Alliance.

Nicotinamide and its effects on endothelial dysfunction and secretion of antiangiogenic factors by primary human placental cells and tissues.

N. Hannan, S. Tong, N. Binder, 2021, Placenta.

Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction

M. Ikawa, L. Parry, Masanaga Muto, 2017, Hypertension.

The effect of metformin on cardiovascular markers in female mice consuming a high fat diet.

N. Hannan, N. Binder, Sally Beard, 2022, Obesity research & clinical practice.

Key players of the necroptosis pathway RIPK1 and SIRT2 are altered in placenta from preeclampsia and fetal growth restriction.

Qi Chen, N. Hannan, S. Tong, 2017, Placenta.

Aurora kinase mRNA expression is reduced with increasing gestational age and in severe early onset fetal growth restriction.

K. Schindler, N. Hannan, S. Tong, 2020, Placenta.

Male obesity is associated with changed spermatozoa Cox4i1 mRNA level and altered seminal vesicle fluid composition in a mouse model.

D. Gardner, J. R. Sheedy, N. Hannan, 2015, Molecular human reproduction.

A wash step at collection of placental biopsies from preeclamptic pregnancies does not adversely affect levels of sFlt-1 or endoglin.

N. Hannan, S. Tong, N. Binder, 2015, Pregnancy hypertension.

Parental diet-induced obesity leads to retarded early mouse embryo development and altered carbohydrate utilisation by the blastocyst.

D. Gardner, N. Binder, M. Mitchell, 2012, Reproduction, fertility, and development.

DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia

N. Hannan, S. Seeho, K. Groom, 2021, Scientific Reports.

DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia

S. Kane, L. Hui, S. Walker, 2021, Scientific reports.

The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.

C. Whitehead, N. Hannan, S. Tong, 2017, Biomedical reports.

NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast

S. Kane, S. Walker, N. Hannan, 2021, Scientific Reports.

Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental Dysfunction

S. Kane, N. Hannan, S. Seeho, 2022, Antioxidants.

Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction – implications for treating preeclampsia

Tuong-Vi Nguyen, N. Hannan, S. Tong, 2018, PloS one.

In vitro embryo outgrowth is a bioassay of in vivo embryo implantation and development

D. Gardner, N. Hannan, N. Binder, 2015 .

Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy.

N. Hannan, N. Binder, Natasha de Alwis, 2021, Trends in molecular medicine.

Pre-Clinical Investigation of Cardioprotective Beta-Blockers as a Therapeutic Strategy for Preeclampsia

N. Hannan, T. MacDonald, S. Tong, 2021, Journal of clinical medicine.

Paternal Diet-Induced Obesity Retards Early Mouse Embryo Development, Mitochondrial Activity and Pregnancy Health

D. Gardner, N. Hannan, N. Binder, 2012, PloS one.

Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia

N. Hannan, N. Binder, Sally Beard, 2023, International journal of molecular sciences.

Sulfasalazine for the treatment of preeclampsia in a nitric oxide synthase antagonist mouse model.

N. Hannan, N. Binder, Sally Beard, 2023, Placenta.

Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro

N. Hannan, N. Binder, Sally Beard, 2022, PloS one.

Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of Preeclampsia

N. Hannan, N. Binder, Sally Beard, 2022, International journal of molecular sciences.

Repurposing existing drugs as a therapeutic approach for the prevention of preterm birth.

N. Hannan, N. Binder, T. Kaitu'u-Lino, 2022, Reproduction.

Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth

A. Hayes, Danielle A. Debruin, N. Hannan, 2023, Scientific Reports.

293. Preclinical assessment of new generation antiplatelet therapies to prevent preeclampsia

Tuong-Vi Nguyen, N. Hannan, S. Tong, 2018, Pregnancy Hypertension.

The New Generation Antiplatelet Agent Prasugrel Represents an Exciting Novel Candidate Therapy for Preeclampsia.

N. Hannan, S. Tong, N. Binder, 2020 .